Abbott Binaxnow At Home Antigen Self Test In Aruba

The BinaxNOW COVID-19 Antigen Self Test has not been FDA cleared or approved. It has been authorized by the FDA under an emergency use authorization. It has been authorized only for the detection of proteins from SARSCoV-2 not for any other viruses or pathogens and are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food Drug and Cosmetic Act 21 U.S.C. 360bbb-3(b)(1) unless the declaration is terminated or authorization is revoked sooner. BinaxNOW COVID-19 Antigen Self Test should be performed twice in 3 days at least 36 hours apart. 2021 Abbott. All rights reserved. BinaxNOW is a trademark of Abbott and used with permission. Any photos displayed are for illustrative purposes only. Any person depicted in such photos is a model.